Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ainos, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
AIMD
Nasdaq
2836
www.ainos.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ainos, Inc.
Ainos and Kenmec Launch Strategic Partnership to Deploy AI-Powered Scent Intelligence in Smart Factories Across Asia
- Jun 24th, 2025 6:00 am
Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25
- Jun 17th, 2025 9:35 am
Ainos Issues Mid-Year Update: Reaching Strategic Inflection in SmellTech and Immunotherapy
- Jun 16th, 2025 6:00 am
Water Tower Research Highlights Ainos' AI Nose Accuracy Breakthrough in Elderly Care Monitoring: SmellTech Gets Smarter
- Jun 3rd, 2025 6:00 am
Ainos AI Nose Improves Accuracy in Hygiene Monitoring To 85% from 80%
- May 29th, 2025 6:00 am
Ainos Showcases Breakthrough AI Nose Technology at COMPUTEX 2025 with Japan's Robotics Partner
- May 22nd, 2025 6:00 am
AINOS (NASDAQ: AIMD) Signs Long-Form Interview and National TV Commercial Agreement with New to The Street
- May 21st, 2025 12:20 pm
Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy
- May 19th, 2025 6:00 am
Water Tower Research Highlights Ainos' Significant Commercial Traction and Strategic Milestones Across Multiple Sectors
- May 14th, 2025 6:00 am
Ainos Reports First Quarter 2025 Financial Results
- May 12th, 2025 6:00 am
Atossa Therapeutics and Ainos Interviews Aired on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
- May 5th, 2025 7:00 am
Ainos Forms Partnership with ASE's Key Site to Power AI-Driven SmellTech in Semiconductor Smart Manufacturing
- Apr 30th, 2025 6:12 am
Water Tower Research Spotlights Ainos' Smell Integration in Humanoid Robot - AI Smelltech is Progressing Rapidly
- Apr 23rd, 2025 6:00 am
Ainos and ugo Complete First Robotic Smell Integration in Japan
- Apr 21st, 2025 6:00 am
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
- Apr 14th, 2025 6:00 am
Water Tower Research Highlights Ainos' AI Nose Expansion into Robotics and Semiconductor Manufacturing - Smell ID Is Scaling
- Apr 11th, 2025 6:00 am
Ainos to Participate in Fireside Chat with Water Tower Research on April 8, 2025
- Mar 24th, 2025 3:00 pm
Water Tower Research Spotlights Ainos & ASE Partnership: Unleashing AI Nose’s Potential in Chip Manufacturing and More
- Mar 13th, 2025 7:00 am
Ainos and ASE Partner to Power AI Scent Digitization in Semiconductor Manufacturing
- Mar 11th, 2025 7:00 am
Ainos Full Year 2024 Earnings: US$1.56 loss per share (vs US$3.36 loss in FY 2023)
- Mar 9th, 2025 6:48 am
Scroll